This pharma company gets approval to set up a new manufacturing facility for its popular drug 'Ibuprofen' This pharma company gets approval to set up a new manufacturing facility for its popular drug 'Ibuprofen' Shares of the company zoomed on getting CEP approval to manufacture Ibuprofen from the Vishakhapatnam facility. Tushar Jain / Tuesday, November 1, 2022 0 13245 Article rating: 4.0 Solara Active Pharma Sciences (Solara) has received ‘Certificate of Suitability (CEP) approval for its new state-of-the-art multipurpose API manufacturing facility at Vishakhapatnam. Read more